In the present study, we employed LC-MS–based and CE-MS–based metabolomics as well as bioinformatics to contribute to the metabolic characterization for ESCC and to explore the relationship of ILF2 and ILF3 with the metabolomic characteristics in ESCC tissues. The gene discussed is ILF3; the disease is esophageal squamous cell carcinoma.